FDA Panel Turns Down Vivus’ Diet Drug

Published July 16, 2010

FDA panel turns down Vivus’ diet drug
A federal regulatory review panel Thursday narrowly voted against an experimental weight-loss drug because of safety concerns, spelling possible trouble for two rival therapies made by San Diego companies that also are seeking government approval.
Read more on San Diego Union-Tribune